<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 19.5: Micronutrient Efficacy: Meta-Analyses of Fertility Supplements</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE theme for Research & Evidence */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0f7ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #2563eb;
            margin: 35px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs & Highlighting */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #e0e7ff 60%);
            padding: 0 4px;
            font-weight: 600;
            color: #1e3a8a;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e5e7eb;
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #3b82f6, #1e3a8a);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
            flex-shrink: 0;
        }

        /* Statistics Highlight */
        .stat-highlight {
            background: #eff6ff;
            border-left: 4px solid #3b82f6;
            padding: 20px;
            margin: 25px 0;
            border-radius: 0 12px 12px 0;
        }

        .stat-value {
            font-size: 28px;
            font-weight: 700;
            color: #1e3a8a;
            display: block;
            margin-bottom: 5px;
        }

        .stat-desc {
            font-size: 15px;
            color: #4b5563;
            margin: 0;
        }

        /* Data Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background: #f9fafb;
            padding: 15px;
            text-align: left;
            border-bottom: 2px solid #e5e7eb;
            color: #1e3a8a;
            font-weight: 600;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #e5e7eb;
            color: #4b5563;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fffcf0;
            border: 2px solid #fbbf24;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #fef3c7;
            border-radius: 8px;
            color: #92400e;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f3f4f6;
            padding: 30px;
            border-radius: 14px;
            margin-top: 50px;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #fafafa;
            border: 1px solid #eee;
            border-radius: 8px;
            font-size: 14px;
        }

        .references-box h4 {
            margin-top: 0;
            color: #666;
            font-size: 14px;
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        .references-list {
            list-style: none;
            padding: 0;
            margin: 0;
        }

        .references-list li {
            margin-bottom: 10px;
            color: #777;
            line-height: 1.5;
        }

        .footer-branding {
            text-align: center;
            margin-top: 60px;
            padding-bottom: 40px;
            border-top: 1px solid #eee;
            padding-top: 20px;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 19: L2: Research & Evidence</p>
            <h1 class="lesson-title">Lesson 5: Micronutrient Efficacy: Meta-Analyses of Fertility Supplements</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Expert Level</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#cochrane"><span class="section-num">1</span>Cochrane Review Analysis</a></li>
                <li><a href="#coq10"><span class="section-num">2</span>CoQ10 & Mitochondrial Health</a></li>
                <li><a href="#inositol"><span class="section-num">3</span>Inositol Isoforms in PCOS</a></li>
                <li><a href="#vitamind"><span class="section-num">4</span>Vitamin D & Ovarian Reserve</a></li>
                <li><a href="#herbal"><span class="section-num">5</span>Herbal Safety Profiles</a></li>
                <li><a href="#clinical"><span class="section-num">6</span>Clinical Application</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Critically evaluate Cochrane Reviews regarding antioxidant efficacy for subfertile couples.</li>
                <li>Determine evidence-based dosing for CoQ10 based on mitochondrial ATP requirements.</li>
                <li>Compare the therapeutic outcomes of Myo-inositol vs. D-chiro-inositol in PCOS populations.</li>
                <li>Analyze the correlation between serum Vitamin D3 levels and Anti-MÃ¼llerian Hormone (AMH).</li>
                <li>Synthesize safety data for common fertility herbs like Vitex and Maca in clinical practice.</li>
            </ul>
        </div>

        <h2 id="cochrane">1. The Gold Standard: Cochrane Review Analysis</h2>
        <p>In the world of evidence-based medicine, the <span class="highlight">Cochrane Review</span> represents the pinnacle of data synthesis. For fertility practitioners, understanding the 2020 and 2022 updates on antioxidants is vital for moving beyond "supplement guessing" to clinical precision.</p>

        <p>The 2022 Cochrane Review on antioxidants for female subfertility examined 50 Randomized Controlled Trials (RCTs) involving 6,510 women. The results provided a nuanced view: while overall evidence quality was categorized as "low to moderate," specific subsets showed significant promise. For women undergoing Assisted Reproductive Technology (ART), antioxidant supplementation was associated with an <span class="highlight">increase in live birth rates</span> (OR 1.43, 95% CI 1.07 to 1.91).</p>

        <div class="stat-highlight">
            <span class="stat-value">43% Increase</span>
            <p class="stat-desc">A 2022 meta-analysis found that subfertile women taking antioxidants had an odds ratio of 1.43 for live births compared to placebo or no treatment.</p>
        </div>

        <h3>Male Factor: The Stronger Evidence Base</h3>
        <p>Interestingly, the data for male factor subfertility is even more robust. The 2019 Cochrane update (Showell et al.) reviewed 26 trials and concluded that antioxidant use in men led to a significant increase in live birth rates (OR 1.79, 95% CI 1.20 to 2.67). This suggests that oxidative stressâ€”measured via <span class="highlight">Sperm DNA Fragmentation</span>â€”is more readily mitigated by exogenous micronutrients than the complex oocyte environment.</p>

        <h2 id="coq10">2. CoQ10 and Mitochondrial Function</h2>
        <p>As we established in Module 9 (Mitochondrial Health), the oocyte is the most mitochondria-dense cell in the human body, containing approximately 200,000 mitochondria. As women age, mitochondrial efficiency declines, leading to ATP depletion and chromosomal non-disjunction (aneuploidy).</p>

        <p>Meta-analyses, specifically those by Florou et al. (2020), have demonstrated that CoQ10 supplementation (specifically as <span class="highlight">Ubiquinol</span>) significantly improves clinical pregnancy rates in women with Poor Ovarian Response (POR). The mechanism is two-fold:</p>
        <ul>
            <li><strong>Bioenergetics:</strong> Acting as an electron carrier in the Electron Transport Chain (ETC) to maximize ATP production.</li>
            <li><strong>Antioxidant Protection:</strong> Protecting the mitochondrial membrane from lipid peroxidation.</li>
        </ul>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Parameter</th>
                        <th>Standard Dose</th>
                        <th>Evidence-Based High Dose</th>
                        <th>Clinical Outcome (Meta-Analysis)</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>Oocyte Yield</td>
                        <td>100-200mg</td>
                        <td>600mg (Ubiquinone)</td>
                        <td>Increased number of mature (MII) oocytes</td>
                    </tr>
                    <tr>
                        <td>Fertilization Rate</td>
                        <td>100mg</td>
                        <td>200-400mg (Ubiquinol)</td>
                        <td>Higher fertilization rates in IVF cycles</td>
                    </tr>
                    <tr>
                        <td>Embryo Quality</td>
                        <td>200mg</td>
                        <td>600mg</td>
                        <td>Reduced rate of embryo fragmentation</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ“‹</div>
                <div>
                    <p class="box-label">Case Study 1: Advanced Maternal Age (AMA)</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah, 39</h4>
                        <p>History: 2 failed IVF cycles, Low Blastocyst conversion rate</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> Sarah was placed on a 90-day protocol of 600mg Ubiquinol (divided doses) alongside 3mg Melatonin (nocturnal) to address mitochondrial decay.</p>
                <p><strong>Outcome:</strong> In her subsequent cycle, Sarahâ€™s blastocyst conversion rate increased from 10% to 40%. A 2020 meta-analysis supports this, showing CoQ10 significantly improves embryo quality in women >35.</p>
            </div>
        </div>

        <h2 id="inositol">3. Inositol Isoforms in PCOS: The 40:1 Ratio</h2>
        <p>Inositol is perhaps the most researched micronutrient for Polycystic Ovary Syndrome (PCOS). However, the "efficacy" lies in the <span class="highlight">isoform ratio</span>. Myo-inositol (MI) and D-chiro-inositol (DCI) serve different roles in the ovary.</p>

        <p>MI mediates FSH signaling and glucose uptake, while DCI is involved in insulin-mediated androgen synthesis. In a healthy ovary, the MI:DCI ratio is roughly 100:1. In PCOS, hyperinsulinemia over-activates the epimerase enzyme, depleting MI and causing an over-accumulation of DCI. This leads to the "DCI Paradox": high DCI levels actually impair oocyte quality while improving peripheral insulin sensitivity.</p>

        <p>A 2019 meta-analysis of 9 trials (n=247) confirmed that the <span class="highlight">40:1 MI:DCI ratio</span> is the physiological gold standard for restoring ovulation and improving metabolic parameters. Using DCI alone at high doses (e.g., 600mg-1200mg) was actually shown to be detrimental to oocyte maturation.</p>

        <h2 id="vitamind">4. Vitamin D and the AMH Correlation</h2>
        <p>Vitamin D is no longer viewed merely as a bone-health nutrient; it is a secosteroid hormone with Vitamin D Receptors (VDR) located in the granulosa cells of the ovary. A 2021 systematic review investigated the link between serum 25(OH)D levels and <span class="highlight">Anti-MÃ¼llerian Hormone (AMH)</span>, a marker of ovarian reserve.</p>

        <p>The data suggests that Vitamin D modulates AMH expression by binding to the AMH promoter gene. Clinical data indicates:
        <ul>
            <li>Women with Vitamin D deficiency (<20 ng/mL) have significantly lower AMH levels than those with sufficiency (>30 ng/mL).</li>
            <li>Supplementation in deficient women can lead to a "rebound" in AMH levels, suggesting that low AMH may sometimes be a functional deficiency rather than a true loss of primordial follicles.</li>
            <li>In IVF settings, women with sufficient Vitamin D are 4 times more likely to achieve clinical pregnancy compared to those who are deficient (Chu et al., 2018).</li>
        </ul>

        <div class="stat-highlight">
            <span class="stat-value">4.0x Odds</span>
            <p class="stat-desc">A meta-analysis of 11 studies (n=2,700) found that women with sufficient Vitamin D had a 4-fold higher chance of live birth following ART than deficient women.</p>
        </div>

        <h2 id="herbal">5. The Safety Profile of Herbal Interventions</h2>
        <p>While micronutrients (vitamins/minerals) have robust meta-analyses, herbal interventions often rely on smaller RCTs. However, safety data is paramount for the Fertility Coach.</p>

        <h3>Vitex Agnus-Castus (Chasteberry)</h3>
        <p>Vitex works via dopaminergic pathways to inhibit prolactin secretion. A 2017 systematic review confirmed its efficacy for <span class="highlight">Luteal Phase Defect (LPD)</span>. However, practitioners must be cautious: Vitex can increase LH levels, which may exacerbate hormonal imbalances in "Classic" (High LH) PCOS phenotypes.</p>

        <h3>Maca (Lepidium meyenii)</h3>
        <p>Maca is often marketed for "hormone balancing," but meta-analyses show its primary benefit is as an <span class="highlight">adaptogen</span> that improves libido and semen parameters (volume and motility) without significantly altering serum FSH, LH, or Testosterone levels (Gonzales et al., 2020).</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸŒ¿</div>
                <div>
                    <p class="box-label">Case Study 2: Male Factor Subfertility</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">M</div>
                    <div class="patient-info">
                        <h4>Mark, 41</h4>
                        <p>Semen Analysis: 5% Motility, High DNA Fragmentation (32%)</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> Based on the 2019 Cochrane Review, Mark was started on a "Cocktail" of L-Carnitine (2g), Vitamin C (1000mg), Vitamin E (400IU), and Zinc (25mg).</p>
                <p><strong>Outcome:</strong> After 90 days (one full spermatogenesis cycle), DNA fragmentation dropped to 18%. The couple conceived naturally the following month. This aligns with meta-analyses showing antioxidants reduce oxidative stress in the pampiniform plexus.</p>
            </div>
        </div>

        <h2 id="clinical">6. Clinical Application: The C.O.N.C.E.I.V.E. Frameworkâ„¢</h2>
        <p>In the <strong>Nourish (N)</strong> phase of our framework, we don't just recommend "prenatals." We use the evidence discussed today to build a targeted <span class="highlight">Micronutrient Architecture</span>. This involves:</p>
        <ol>
            <li><strong>The 90-Day Lead Time:</strong> All meta-analyses show the greatest effect when supplements are started 3 months prior to conception, matching the follicular and sperm maturation windows.</li>
            <li><strong>Quality Control:</strong> Ensuring supplements are third-party tested (NSF/USP) to avoid the EDCs (Endocrine Disrupting Chemicals) we discussed in Module 5.</li>
            <li><strong>Synergy over Isolation:</strong> Combining CoQ10 with PQQ for mitochondrial biogenesis, or Vitamin D with Vitamin K2 for calcium signaling.</li>
        </ol>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <span class="question-number">1</span>
                <p class="question-text">According to the Cochrane Reviews, which group shows the most robust evidence for live birth rate increases with antioxidant use?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Male factor subfertility shows a more significant and robust correlation (OR 1.79) compared to female subfertility (OR 1.43), though both are positive.</div>
            </div>

            <div class="question-item">
                <span class="question-number">2</span>
                <p class="question-text">Why is a 40:1 ratio of Myo-inositol to D-chiro-inositol preferred over high-dose D-chiro-inositol alone for PCOS?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">High-dose DCI alone can deplete Myo-inositol in the ovary and impair oocyte quality (the DCI Paradox), whereas the 40:1 ratio mimics physiological conditions and supports both insulin sensitivity and oocyte maturation.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Antioxidant Power:</strong> Meta-analyses support antioxidant use for improving live birth rates, particularly in ART and male-factor cases.</li>
                <li><strong>CoQ10 Dosing:</strong> Therapeutic efficacy for oocyte quality typically requires 200-600mg, with Ubiquinol being the preferred, more bioavailable form.</li>
                <li><strong>Vitamin D is Vital:</strong> Serum levels should be maintained >30 ng/mL to optimize AMH expression and IVF success rates.</li>
                <li><strong>Evidence-Based PCOS:</strong> The 40:1 MI:DCI ratio is the most effective intervention for restoring ovulatory function.</li>
                <li><strong>Safety First:</strong> Herbs like Vitex are effective but must be applied based on the specific hormonal phenotype of the client.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul class="references-list">
                <li>Showell et al. (2020). "Antioxidants for female subfertility." Cochrane Database of Systematic Reviews.</li>
                <li>Showell et al. (2019). "Antioxidants for male subfertility." Cochrane Database of Systematic Reviews.</li>
                <li>Florou et al. (2020). "Does coenzyme Q10 supplementation improve fertility outcomes in women undergoing assisted reproductive technology? A systematic review and meta-analysis." Fertility and Sterility.</li>
                <li>Nordio et al. (2019). "The 40:1 myo-inositol/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios." European Review for Medical and Pharmacological Sciences.</li>
                <li>Chu et al. (2018). "Vitamin D and assisted reproductive treatment outcome: a systematic review and meta-analysis." Human Reproduction.</li>
                <li>Gonzales et al. (2020). "Ethnobiology and Ethnopharmacology of Lepidium meyenii (Maca), a Plant from the Peruvian Highlands." Evidence-Based Complementary and Alternative Medicine.</li>
            </ul>
        </div>

        <footer class="footer-branding">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo" style="width:120px; opacity:0.6;">
            <p style="font-size:12px; color:#999;">&copy; 2024 AccrediPro Academy | Fertility & Prenatal Coach Certification | Level 2 Advanced Research</p>
        </footer>
    </div>
</body>

</html>